Abstract
Hypertrophic scar (HTS) is a common outcome of deep dermal wound healing mainly followed mechanical, chemical, and thermal injuries in the skin. Because of the lack of the most effective prevention and treatment, it is particularly important to establish an ideal dermal animal model for improving the understanding of the pathogenesis and exploring therapeutic approaches of HTS. Compared to other dermal fibrotic animal models in rabbits, red Duroc pigs, guinea pigs, rats, and mice, the approach that uses normal human split-thickness skin grafted onto nude or other immunodeficient mice which develop scars that resemble human HTS offers the advantages of lower cost, easier manipulation, and shorter research period. In this chapter, we will introduce the detailed procedures to create the ideal dermal fibrotic mouse model.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ding J, Tredget EE (2015) Cellular and molecular mechanism of dermal fibrosis following burn injury, and exploration of therapeutic approaches. J Aesthet Reconstr Surg 1(1):6. doi:10.4172/2472-1905.10003
Ding J, Tredget EE (2015) The role of chemokines in fibrotic wound healing. Adv Wound Care (New Rochelle) 4(11):673–686. doi:10.1089/wound.2014.0550
Gauglitz GG, Korting HC, Pavicic T et al (2011) Hypertrophic scarring and keloids: pathomechanisms and current and emerging treatment strategies. Mol Med 17(1–2):113–125. doi:10.2119/molmed.2009.00153
Tredget EE, Ding J (2009) Wound healing: from embryos to adults and back again. Lancet 373(9671):1226–1228. doi:10.1016/S0140-6736(09)60705-4
Tziotzios C, Profyris C, Sterling J (2012) Cutaneous scarring: pathophysiology, molecular mechanisms, and scar reduction therapeutics part II. Strategies to reduce scar formation after dermatologic procedures. J Am Acad Dermatol 66(1):13–24. doi:10.1016/j.jaad.2011.08.035
Stewart TL, Ball B, Schembri PJ et al (2012) The use of laser Doppler imaging as a predictor of burn depth and hypertrophic scar Postburn injury. J Burn Care Res 33(6):764–771. doi:10.1097/BCR.0b013e318257db36
Kwan P, Ding J, Tredget EE (2015) MicroRNA 181b regulates Decorin production by dermal fibroblasts and may be a potential therapy for hypertrophic scar. PLoS One 10(4). doi:10.1371/journal.pone.0123054
Qing C, Wang ZY, Song F et al (2016) Dynamic biological changes in fibroblasts during hypertrophic scar formation and regression. Int Wound J 13(2):257–262. doi:10.1111/iwj.12283
Tredget EE, Yang L, Delehanty M et al (2006) Polarized Th2 cytokine production in patients with hypertrophic scar following thermal injury. J Interf Cytokine Res 26(3):179–189. doi:10.1089/jir.2006.26.179
Wong VW, Paterno J, Sorkin M et al (2011) Mechanical force prolongs acute inflammation via T-cell-dependent pathways during scar formation. FASEB J 25(12):4498–4510. doi:10.1096/fj.10-178087
Wang J, Hori K, Ding J et al (2011) Toll-like receptors expressed by dermal fibroblasts contribute to hypertrophic scarring. J Cell Physiol 226(5):1265–1273. doi:10.1002/jcp.22454
Wynn TA (2008) Cellular and molecular mechanisms of fibrosis. J Pathol 214(2):199–210. doi:10.1002/path.2277
Wang J, Ding J, Jiao H et al (2011) Human hypertrophic scar-like nude mouse model: characterization of the molecular and cellular biology of the scar process. Wound Repair Regen 19(2):274–285. doi:10.1111/j.1524-475X.2011.00672.x
Liu HB, Ding J, Ma ZS et al (2015) A novel subpopulation of peripheral blood mononuclear cells presents in major burn patients. Burns 41(5):998–1007. doi:10.1016/j.burns.2014.12.005
Zhu Z, Ding J, Ma Z et al (2016) Systemic depletion of macrophages in the subacute phase of wound healing reduces hypertrophic scar formation. Wound Repair Regen 24(4):644–656. doi:10.1111/wrr.12442
Wong VW, Rustad KC, Akaishi S et al (2012) Focal adhesion kinase links mechanical force to skin fibrosis via inflammatory signaling. Nat Med 18(1):148–152. doi:10.1038/nm.2574
Ding J, Hori K, Zhang R et al (2011) Stromal cell-derived factor 1 (SDF-1) and its receptor CXCR4 in the formation of postburn hypertrophic scar (HTS). Wound Repair Regen 19(5):568–578. doi:10.1111/j.1524-475X.2011.00724.x
Ding J, Ma Z, Liu H et al (2014) The therapeutic potential of a C-X-C chemokine receptor type 4 (CXCR-4) antagonist on hypertrophic scarring in vivo. Wound Repair Regen 22(5):622–630. doi:10.1111/wrr.12208
Ghahary A, Shen YJ, Nedelec B et al (1996) Collagenase production is lower in post-burn hypertrophic scar fibroblasts than in normal fibroblasts and is reduced by insulin-like growth factor-1. J Invest Dermatol 106(3):476–481. doi:10.1111/1523-1747.ep12343658
Scott PG, Dodd CM, Tredget EE et al (1996) Chemical characterization and quantification of proteoglycans in human post-burn hypertrophic and mature scars. Clin Sci (Lond) 90(5):417–425. doi:10.1042/cs0900417
Nedelec B, Shankowsky H, Scott PG et al (2001) Myofibroblasts and apoptosis in human hypertrophic scars: the effect of interferon-alpha2b. Surgery 130(5):798–808. doi:10.1067/msy.2001.116453
Wang J, Dodd C, Shankowsky HA et al (2008) Deep dermal fibroblasts contribute to hypertrophic scarring. Lab Investig 88(12):1278–1290. doi:10.1038/labinvest.2008.101
Honardoust D, Ding J, Varkey M et al (2012) Deep dermal fibroblasts refractory to migration and decorin-induced apoptosis contribute to hypertrophic scarring. J Burn Care Res 33(5):668–677. doi:10.1097/BCR.0b013e31824088e3
Kwan P, Hori K, Ding J et al (2009) Scar and contracture: biological principles. Hand Clin 25(4):511–528. doi:10.1016/j.hcl.2009.06.007
Seo BF, Lee JY, Jung SN (2013) Models of abnormal scarring. Biomed Res Int 2013:423147. doi:10.1155/2013/423147
Silverstein P, Goodwin M Jr, Raulston G (1972) Hypertrophic scarring, etiology and control of a disabling complication in burned soldiers. Ann Res Prog Rep US Army Instit Surg Res Sec 37:1–5
Silverstein P, Goodwin MN, Raulston GL et al (1976) Hypertrophic scar in the experimental animal. In: Longacre JJ (ed) The ultrastructure of collagen; its relation to the healing of wounds and to the management of hypertrophic scar. Thomas, Springfield, IL, pp 213–236
Zhu KQ, Engrav LH, Gibran NS et al (2003) The female, red Duroc pig as an animal model of hypertrophic scarring and the potential role of the cones of skin. Burns 29(7):649–664. doi:10.1016/S0305-4179(03)00205-5
Zhu KQ, Engrav LH, Tamura RN et al (2004) Further similarities between cutaneous scarring in the female, red Duroc pig and human hypertrophic scarring. Burns 30(6):518–530. doi:10.1016/j.burns.2004.02.005
Sood RF, Muffley LA, Seaton ME et al (2015) Dermal fibroblasts from the red Duroc pig have an inherently Fibrogenic phenotype: an in vitro model of Fibroproliferative scarring. Plast Reconstr Surg 136(5):990–1000. doi:10.1097/prs.0000000000001704
Le Provost GS, Pullar CE (2015) beta2-adrenoceptor activation modulates skin wound healing processes to reduce scarring. J Invest Dermatol 135(1):279–288. doi:10.1038/jid.2014.312
Gallant CL, Olson ME, Hart DA (2004) Molecular, histologic, and gross phenotype of skin wound healing in red Duroc pigs reveals an abnormal healing phenotype of hypercontracted, hyperpigmented scarring. Wound Repair Regen 12(3):305–319. doi:10.1111/j.1067-1927.2004.012311.x
Mustoe TA, Pierce GF, Morishima C et al (1991) Growth factor-induced acceleration of tissue repair through direct and inductive activities in a rabbit dermal ulcer model. J Clin Invest 87(2):694–703. doi:10.1172/jci115048
Morris DE, Wu L, Zhao LL et al (1997) Acute and chronic animal models for excessive dermal scarring: quantitative studies. Plast Reconstr Surg 100(3):674–681
Li Y, Kilani RT, Rahmani-Neishaboor E et al (2014) Kynurenine increases matrix metalloproteinase-1 and -3 expression in cultured dermal fibroblasts and improves scarring in vivo. J Invest Dermatol 134(3):643–650. doi:10.1038/jid.2013.303
Zhang Q, Liu LN, Yong Q et al (2015) Intralesional injection of adipose-derived stem cells reduces hypertrophic scarring in a rabbit ear model. Stem Cell Res Ther 6:145. doi:10.1186/s13287-015-0133-y
Çaliskan E, Gamsizkan M, Açikgoz G et al (2016) Intralesional treatments for hypertrophic scars: comparison among corticosteroid, 5-fluorouracil and botulinum toxin in rabbit ear hypertrophic scar model. Eur Rev Med Pharmacol Sci 20(8):1603–1608
Rha EY, Kim YH, Kim TJ et al (2016) Topical application of a silicone gel sheet with verapamil microparticles in a rabbit model of hypertrophic scar. Plast Reconstr Surg 137(1):144–151. doi:10.1097/prs.0000000000001889
Yamamoto T, Takagawa S, Katayama I et al (1999) Animal model of sclerotic skin. I: local injections of bleomycin induce sclerotic skin mimicking scleroderma. J Invest Dermatol 112(4):456–462. doi:10.1046/j.1523-1747.1999.00528.x
Matsushita M, Yamamoto T, Nishioka K (2004) Upregulation of interleukin-13 and its receptor in a murine model of bleomycin-induced scleroderma. Int Arch Allergy Immunol 135(4):348–356. doi:10.1159/000082331
Serratrice N, Bruzzese L, Magalon J et al (2014) New fat-derived products for treating skin-induced lesions of scleroderma in nude mice. Stem Cell Res Ther 5(6):138. doi:10.1186/scrt528
Ruzehaji N, Avouac J, Elhai M et al (2015) Combined effect of genetic background and gender in a mouse model of bleomycin-induced skin fibrosis. Arthritis Res Ther 17:145. doi:10.1186/s13075-015-0659-5
Ohashi T, Yamamoto T (2015) Antifibrotic effect of lysophosphatidic acid receptors LPA1 and LPA3 antagonist on experimental murine scleroderma induced by bleomycin. Exp Dermatol 24(9):698–702. doi:10.1111/exd.12752
Aksoy MH, Vargel I, Canter IH et al (2002) A new experimental hypertrophic scar model in guinea pigs. Aesthet Plast Surg 26(5):388–396. doi:10.1007/s00266-002-1121-z
Rittié L (2016) Cellular mechanisms of skin repair in humans and other mammals. J Cell Commun Signal 10(2):103–120. doi:10.1007/s12079-016-0330-1
Polo M, Kim YJ, Kucukcelebi A et al (1998) An in vivo model of human proliferative scar. J Surg Res 74(2):187–195. doi:10.1006/jsre.1997.5251
Wang X, Smith P, Pu LL et al (1999) Exogenous transforming growth factor beta(2) modulates collagen I and collagen III synthesis in proliferative scar xenografts in nude rats. J Surg Res 87(2):194–200. doi:10.1006/jsre.1999.5757
Hochman B, Vilas Boas FC, Mariano M et al (2005) Keloid heterograft in the hamster (Mesocricetus auratus) cheek pouch, Brazil. Acta Cir Bras 20(3):200–212. doi:S0102-86502005000300003
Yang DY, Li SR, Wu JL et al (2007) Establishment of a hypertrophic scar model by transplanting full-thickness human skin grafts onto the backs of nude mice. Plast Reconstr Surg 119(1):104–109. doi:10.1097/01.prs.0000244828.80490.62. discussion 110-101
Momtazi M, Ding J, Kwan P et al (2015) Morphologic and histologic comparison of hypertrophic scar in nude mice, T-cell receptor, and recombination activating gene knockout mice. Plast Reconstr Surg 136(6):1192–1204. doi:10.1097/PRS.0000000000001782
Alrobaie S, Ding J, Ma Z et al (2015) A novel nude mouse model of hypertrophic scarring using scratched full-thickness human skin grafts. Wound Repair Regen 23(4):A2–A2. doi:10.1089/wound.2015.0670
Dunkin CSJ, Pleat JM, Gillespie PH et al (2007) Scarring occurs at a critical depth of skin injury: precise measurement in a graduated dermal scratch in human volunteers. Plast Reconstr Surg 119(6):1722–1732. doi:10.1097/01.prs.0000258829.07399.f0
Acknowledgment
This work was supported by Firefighter’s Burn Trust Fund, Edmonton Civic Employees Research Awards, and University of Alberta Hospital Foundation.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Science+Business Media LLC
About this protocol
Cite this protocol
Ding, J., Tredget, E.E. (2017). Transplanting Human Skin Grafts onto Nude Mice to Model Skin Scars. In: Rittié, L. (eds) Fibrosis. Methods in Molecular Biology, vol 1627. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-7113-8_5
Download citation
DOI: https://doi.org/10.1007/978-1-4939-7113-8_5
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-7112-1
Online ISBN: 978-1-4939-7113-8
eBook Packages: Springer Protocols